ArticleOncogene2021

Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations.

Maryam Shariati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.